AB Science S.A./€AB
05:30
09:10
12:45
16:25
20:00
1D1W1MYTD1Y5YMAX
About AB Science S.A.
AB Science S.A. is a biotechnology company based in Paris, France, specializing in the research, development, and commercialization of protein kinase inhibitors. These are used in the treatment of cancers, chronic inflammatory diseases, and neurodegenerative disorders. Established in 2001, the company targets diseases with significant unmet medical needs through proprietary compounds, notably masitinib which is in various stages of clinical trials. AB Science operates primarily in Europe and has various products in its pipeline aimed at both human and veterinary medicine. Its strategic focus on niche therapeutic areas where there are few treatment options gives it a distinct position in the pharmaceutical industry.
Ticker
€AB
Sector
Primary listing
PAR
Employees
36
Headquarters
Website
AB Science S.A. Metrics
BasicAdvanced
€67m
-
-€0.03
1.22
-
Price and volume
Market cap
€67m
Beta
1.22
52-week high
€1.75
52-week low
€0.87
Average daily volume
32k
Financial strength
Interest coverage (TTM)
0.19%
Profitability
EBITDA (TTM)
1.033
Gross margin (TTM)
83.30%
Net profit margin (TTM)
-132.62%
Operating margin (TTM)
54.43%
Revenue per employee (TTM)
€30,000
Management effectiveness
Valuation
Price to revenue (TTM)
45.358
Growth
Revenue change (TTM)
9.51%
Earnings per share change (TTM)
-80.00%
3-year revenue growth (CAGR)
7.01%
10-year revenue growth (CAGR)
-6.44%
3-year earnings per share growth (CAGR)
-53.06%
10-year earnings per share growth (CAGR)
-27.82%
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Market data provided by CBOE Europe and Deutsche Börse.
FAQs